Literature DB >> 11298587

Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.

C Nisse1, J M Haguenoer, B Grandbastien, C Preudhomme, B Fontaine, J M Brillet, R Lejeune, P Fenaux.   

Abstract

Aetiological factors of the myelodysplastic syndromes (MDS) are largely unknown, with the exception of alkylating agents, ionizing radiation and benzene. Some other risk factors have been suggested by the few epidemiological studies reported (solvents, ammonia, exhaust gases, metals, pesticides, alcohol). We performed a case-control study to assess the relationship between occupational or environmental factors and MDS. Two hundred and four patients with newly diagnosed MDS, and 204 sex- and age-matched controls were included. Medical history, demographic data, lifetime exposure and hobbies were obtained. Qualitative and quantitative exposure to chemical and physical hazards were evaluated with the patients and reviewed by a group of experts in occupational exposure. The median age was 70 years and 62% of the patients were men. In univariate analyses, we found relationships between MDS and smoking habits, gardening, occupations such as health professionals, technical and sale representatives, machine operators, agricultural workers, textile workers, qualitative occupational exposures (exposed/non-exposed) to oil, solvents, ammonia, pesticides, fertilizers, cereal dusts, contact with poultry or livestock and infective risk, and lifetime cumulative exposure to solvents, oil, textile dust and infective risk. The main risk factors of MDS determined by multivariate analyses (conditional logistic regression) were, being an agricultural worker [odds ratio (OR) = 3.66; 95% confidence interval (CI) 1.9-7.0], textile operator (OR = 3.66; 95% CI 1.9-7.9), health professional (OR = 10.0; 95% CI 2.1-48.7), commercial and technical sale representative (OR = 4.45; 95% CI 1.4-14.6), machine operator (OR = 2.69; 95% CI 1.2-6.0), living next to an industrial plant (OR = 2.45; 95% CI 1.5-4.1), smoking (OR = 1.74; 95% CI 1.1-2.7) and lifetime cumulative exposure to oil (OR = 1.1; 95% CI 1.0-1.2). Further studies should be performed to assess specific exposures more precisely and it would be of interest to develop a map of haematological malignancies according to industrial background.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298587     DOI: 10.1046/j.1365-2141.2001.02645.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

Review 1.  Epidemiology of myelodysplastic syndromes.

Authors:  Xiaomei Ma
Journal:  Am J Med       Date:  2012-07       Impact factor: 4.965

2.  Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.

Authors:  Jenny N Poynter; Michaela Richardson; Michelle Roesler; Cindy K Blair; Betsy Hirsch; Phuong Nguyen; Adina Cioc; James R Cerhan; Erica Warlick
Journal:  Int J Cancer       Date:  2016-09-24       Impact factor: 7.396

Review 3.  Important features of myelodysplastic syndrome.

Authors:  Wolf K Hofmann; H Phillip Koeffler
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 4.  What's all the fuss about? facts and figures about bone marrow failure and conditions.

Authors:  Sudipto Mukherjee; Mikkael A Sekeres
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

5.  Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.

Authors:  Amy M Linabery; Michelle A Roesler; Michaela Richardson; Erica D Warlick; Phuong L Nguyen; Adina M Cioc; Jenny N Poynter
Journal:  Cancer Epidemiol       Date:  2022-01-05       Impact factor: 2.984

6.  Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies.

Authors:  Charikleia Kelaidi; Aspasia Stamatoullas; Odile Beyne-Rauzy; Emmanuel Raffoux; Bruno Quesnel; Agnes Guerci; François Dreyfus; Sabine Brechignac; Christian Berthou; Thomas Prebet; Yosr Hicheri; Maya Hacini; Jacques Delaunay; Marie-Pierre Gourin; Jean-Marie Camo; Hacene Zerazhi; Anne-Laure Taksin; Laurence Legros; Bachra Choufi; Pierre Fenaux
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

Review 7.  Oxidative stress and the myelodysplastic syndromes.

Authors:  Morag J Farquhar; David T Bowen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

8.  A nationwide non-interventional epidemiological data registry on myelodysplastic syndromes in Lebanon.

Authors:  Zaher K Otrock; Nabil Chamseddine; Ziad M Salem; Tarek Wehbe; Mouna Al-Ayoubi; Moussa Dhaini; Joseph Kattan; Walid Mokaddem; Therese Abi Nasr; Oussama Jradi; Fadi S Farhat; Mahmoud Wehbe; Mohammad H Haidar; Mohamed A Kharfan-Dabaja; Nizar Bitar; Mirna El Hajj; Adel M Kadri; Francois G Kamar; Hanan Yassine; Hassan Khodr; Ali T Taher; Noha Hakime; Rami Ar Mahfouz; Wassim Serhal; Ali Bazarbachi; Hussein Z Farhat
Journal:  Am J Blood Res       Date:  2015-12-25

9.  Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort.

Authors:  Xiaomei Ma; Unhee Lim; Yikyung Park; Susan T Mayne; Rong Wang; Patricia Hartge; Albert R Hollenbeck; Arthur Schatzkin
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

10.  Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.

Authors:  M E Kroll; F Murphy; K Pirie; G K Reeves; J Green; V Beral
Journal:  Br J Cancer       Date:  2012-08-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.